BNP Paribas Financial Markets
TMDX icon

BNP Paribas Financial Markets’s Transmedics TMDX Stock Holding History

BNP Paribas Financial Markets’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.4M Sell
96,337
-48,192
-33% -$4.08M ﹤0.01% 1928
2026
Q1 		$14.4M Sell
144,529
-65,000
-31% -$8.48M 0.01% 1364
2025
Q4 		$25.5M Sell
209,529
-541
-0.3% -$67.9K 0.01% 1045
2025
Q3 		$23.6M Buy
210,070
+12,588
+6% +$1.47M 0.01% 1027
2025
Q2 		$26.5M Buy
197,482
+186,469
+1,693% +$20.5M 0.02% 900
2025
Q1 		$741K Sell
11,013
-535
-5% -$36.8K ﹤0.01% 2971
2024
Q4 		$720K Buy
11,548
+1,170
+11% +$109K ﹤0.01% 3047
2024
Q3 		$1.63M Sell
10,378
-141,542
-93% -$21.8M ﹤0.01% 2164
2024
Q2 		$22.9M Buy
151,920
+134,530
+774% +$16.1M 0.02% 708
2024
Q1 		$1.29M Buy
17,390
+4,518
+35% +$372K ﹤0.01% 2337
2023
Q4 		$1.02M Sell
12,872
-12,014
-48% -$725K ﹤0.01% 2383
2023
Q3 		$1.36M Sell
24,886
-74,253
-75% -$5.35M ﹤0.01% 2131
2023
Q2 		$8.33M Buy
99,139
+13,838
+16% +$1.06M 0.01% 987
2023
Q1 		$6.46M Buy
85,301
+39,362
+86% +$2.72M 0.01% 1112
2022
Q4 		$2.84M Buy
45,939
+14,613
+47% +$777K ﹤0.01% 1578
2022
Q3 		$1.31M Buy
31,326
+25,328
+422% +$1.1M ﹤0.01% 2276
2022
Q2 		$189K Buy
5,998
+3,705
+162% +$98.8K ﹤0.01% 3113
2022
Q1 		$61.8K Sell
2,293
-3,301
-59% -$59.1K ﹤0.01% 3510
2021
Q4 		$107K Buy
5,594
+551
+11% +$13.8K ﹤0.01% 3577
2021
Q3 		$167K Buy
5,043
+4,166
+475% +$127K ﹤0.01% 3110
2021
Q2 		$29.1K Sell
877
-2,337
-73% -$64.8K ﹤0.01% 3439
2021
Q1 		$133K Sell
3,214
-2,072
-39% -$63.8K ﹤0.01% 3223
2020
Q4 		$105K Sell
5,286
-1,111
-17% -$16.4K ﹤0.01% 3182
2020
Q3 		$88.2K Buy
6,397
+5,612
+715% +$96.1K ﹤0.01% 3190
2020
Q2 		$14.1K Sell
785
-3,610
-82% -$56.5K ﹤0.01% 3555
2020
Q1 		$53.1K Buy
4,395
+2,173
+98% +$36.4K ﹤0.01% 3509
2019
Q4 		$42.2K Buy
2,222
+1,388
+166% +$25.5K ﹤0.01% 3728
2019
Q3 		$19.8K Buy
834
+774
+1,290% +$18.6K ﹤0.01% 3951
2019
Q2 		$1.74K Buy
+60
New +$1.64K ﹤0.01% 4332

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

BNP Paribas Financial Markets's TMDX Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Transmedics (TMDX) stake by 33% in Q2 2026, selling an estimated $4.08M and leaving 96,337 shares worth $6.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

BNP Paribas Financial Markets first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $26.5M in Q2 2025. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • BNP Paribas Financial Markets held 96,337 shares of Transmedics worth $6.4M as of Q2 2026.
  • BNP Paribas Financial Markets sold 48,192 Transmedics shares in Q2 2026, an estimated $4.08M.
  • Transmedics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1928 holding.
  • BNP Paribas Financial Markets first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
  • BNP Paribas Financial Markets's Transmedics position peaked at $26.5M in Q2 2025.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.